qxd
|
|
- みいか ちゅうか
- 5 years ago
- Views:
Transcription
1 BD FACS TM Review Vol.7 BD FACSAria TM BD FACSAria FACS HLA-FACS Key words: HLA FACS 1988 Eliane Glukmann Fanconi % 30% mixed chimerism HLA human leukocyte antigen HLAFACS fluorescence activated cell sortor HLA-FACS I. fluorescence in situ hybridization FISH X/Y-FISH 2 short tandem repeat STR PCR STR-PCR 3 FACS FACS 1 HLA 2 HLA HLA FACS3 FACS
2 1. HLA graft versus host disease GVHD major histocompatibility complx; MHC HLA-A BDR 6 A B DR HLA1 2 GVHD HLA 2 795% MHCI HLA-A B 1 HLA HLA HLA-A2 HLA-B5 HLA HLA 2. HLA HLA 3. FACS FACS StanfordLeonald A. Herzenberg FACS-I Stanford FACS Facility FACS Pattern Sorter APC-Cy7 PE-Cy7 FACS Becton Dickinson BD FACS 1995 BD FACSVantage SE 2003 BD FACSAria BD 1 BD FACSAria 9 10 HLA HLA HLA HLA-AB HLA-DRDNA 1964 UCLA Paul I. Terasaki lymphocyte cytotoxicity test; LCT HLA HLA HLA HLA HLA LCTHLA-A B HLA HLA cross-reactive group One Lambda Terasaki HLA HLA HLA 5, 6 HLA HLA HLA 7 2
3 II acute myelogenous leukemia AML M mllineage ml AML/ETO FISH 2 myelodysplastic syndrome MDS RAEB mllineage STR-PCR HLA-FACS HLA One LambdaPacific Orange-CD14 Invitrogen BD HLA-A11 biotin 1 Stain 1 Stain 3 SA-PE Stain 2 SA-APC 2 HLA- A11 biotinhla-a26 1) HLAFITC PE lineage 1 Stain 1 Stain 2 2) HLA 1 Stain 3 FITC PE PE-Texas Red PerCP-Cy5.5 PE-Cy7 APC APC-Cy7 Pacific Blue Pacific Orange Detector Blue-E Blue-D Blue-C Blue-B Blue-A Red-B Red-A Violet-B Violet-A Stain 1 HLA-A24 HLA-A11 PI CD8 CD3 CD56 CD19 CD4 CD14 Stain 2 HLA-A24 CD11b PI HLA-A11 Stain 3 HLA-A24 HLA-A11 PI HLA-DR CD33 CD34 CD56 CD45 CD HLA-A11 biotin1 Stain 1 Stain 3 SA-PE Stain 2 SA-APC 2 HLA-A11 biotinhla-a26 Alexa Red Laser APC(Red-C), Alexa700(Red-B), APC-Cy7(Red-A)Alexa700PMT 685LP, 712/21BP 3
4 3. FACS 1) 5 10 ml 2) 50 ml Ficoll 15 ml 15mL Ficoll 4 mlpbs(-) 1.5 2,000 rpm 20OFF 3) Ficoll 50 ml 4) PBS(-) 1 PBS(-) 1 5) 100 µl 5% PBS(-) 6) FACS ) PBS(-) µl PBS(-) 1 µg/ml propidium iodide PIBD FACSAriaPI PE-TR FCS FlowJo Treestar III. 1. 1lineage T 4 1 TCD4 + T 2 BNK % % 3 5 NK ( 3) ml Stain 1 Stain 2 1PI BD FACSAria TBNK 1 TT
5 ml Stain 1 Stain 2 1 FSC-SSC PI CD4 + TCD8 + TBNK ml Stain
6 2. CD34-CD45 49 CD34 - CD45 + CD34 + CD45 dim 4A 4B 4AG2 G8 2 G2 G8 HLA HLA 4A CD34-CD45 G1 G8 G1CD34 Bright G6 CD34-CD45 4B 4A Stain 3 1 4A 49PIPI-CD34 CD45 G1 G8 8 PI- HLA G2 CD34 + CD45 dim G8 CD34 - CD45 + 4B G1 G8 CD14 CD34-CD45 4B 140 4B 6
7 3. 2 GVHD A CsA CD8 + T IFN B HLA-FACS STR-PCR STR-PCR 3 7 HLA-FACS 5 STR-PCR HLA-FACS CD34 + CD45 dim CD34 + CD45 dim 0.3% 1% FISH AML1/ETO 5% HLA-FACS 320 CD34 + CD45 dim 6 CD56 HLA-DR CD567 AML1/ETO 0% 7 100% 7 CD34 + CD45 dim FACSSTR-PCR CsACD8 + T IFN-CsA CsA CsA CD8 + TIFN- CsA PMA4CD8 IFN
8 ml Stain 3 1 AML-M2CD34 + CD45 dim CD34-CD45CD34 + CD45 dim 7 CD34 + CD45 dim ml Stain 3 1 AML-M2 CD34 + CD45 dim HLA-DR CD56 AML1/ETO FISH 8
9 IV. HLA-FACS 1 2 HLA-FACS BD FACSAria Windows BD FACSAria BD FACSAria Takahashi S, Ooi J, Tomonari A, et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood. 2007;109: Turkiewicz D, Gorczynska E, Toporski J, et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation (allosct) by dual-color FISH analysis of X and Y chromosomes. Leuk Res. 2003;27: Thiede C, Florek M, Bornhauser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant. 1999;23: Sijpkens YW, Doxiadis, II, De Fijter JW, et al. Sharing cross-reactive groups of MHC class I improves long-term graft survival. Kidney Int. 1999;56: Pei R, Chen T, Orpilla J, Lee JH. A simultaneous negative and positive selection method that can detect chimerism at a frequency of 1 per 10,000 by flow cytometry. Tissue Antigens. 1997;50: Metes D, Logar A, Rudert WA, et al. Four-color flow cytometric analysis of peripheral blood donor cell chimerism. Hum Immunol. 2003;64: Piazza A, Poggi E, Ozzella G, et al. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques. Transplantation. 2006;81: Mascher B, Schlenke P, Seyfarth M. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J Immunol Methods. 1999;223:
10 1. BD FACSAria 10 FITC Alexa Fluor 488 PE PerCP-Cy5.5 PE-Cy7 PE-Texas Red APC Alexa Fluor 700 APC-Cy7 Pacific Blue Alexa Fluor 405 Pacific Orange a) FITC PEAPC HLA-FACS HLAFITC PE APC b) PE-Cy7 Alexa Fluor 700 APC-Cy7 Pacific Blue Alexa Fluor 405 Pacific Orange APC- Cy7-CD19 Pacific Blue-CD4 c) PE-TR FITC PE PerCP-Cy5.5 PE-Cy7 Pacific Orange 610/20PI d) PerCP-Cy5.5 APC-Cy7 PE-Cy7 X Y Log Bi-exponential Version 4.1DiVa PC PC e) Pacific Blue Alexa Fluor 405 Pacific Orange f) Pacific Orange 488nm 2. a) 5 6 BD TM CompBeads BD TM CompBead 100 CD4 PE-Cy7CD8 PE-Cy7 b) 10
11 FITC or Alexa488: PE PE-TR Pacific Orange PE: FITC PerCP-Cy5.5 PE-Cy7 PE-TR PerCP-Cy5.5: PE-Cy7 APC Alexa700 APC-Cy7 PE-Cy7: PE PerCP-Cy5.5 PE-TR APC-Cy7 PI: FITC PE PerCP-Cy5.5 PE-Cy7 APC PLOFILE APC: PerCP-Cy5.5 Alexa700 APC-Cy7 Alexa700: APC APC-Cy7 APC-Cy7: PE-Cy7 APC Alexa700 Pacific Blue or Alexa Fluor 405: Pacific Orange Pacific Orange: FITC PE PerCP-Cy5.5 PE-TR FACS BD FACSAria BD FACSDiVa FITC PE HLA MHCI 2 FACS FACS FITC-PE
12 BD BD Becton, Dickinson and Company 2007 BD R
MACS機器予算申請カタログ
MACS Instruments MACSQuant automacs MultiMACS gentlemacs MACSmix TM MACSQuant 3 MACSQuant Analyzer 10 MACSQuant VYBMACSQuant X MACSQuant X Coming soon! 384 well plate Laser Channel Filter (nm) Dye or Parameter
More information日本組織適合性学会誌第23巻2号
Major Histocompatibility Complex 2016; 23 (2): 115 122 HLA 1 1) 1) HLA MHC 1900 HLA HLA キーワード : HLA HLA HLA HLA 2 HLA HLA HLA 3 1 1 HLA HLA 図 1 2016 6 30 2016 8 2 105 0013 1 10 14 3 5 TEL: 03 5776 0048
More information16 MHC 2018; 25 (1) 参加費 1 2, , ,000 会議等 :00 13: :00 13: :20 会場地図 TEL JR 350 m 57
Major Histocompatibility Complex 2018; 25 (1): 56 82 抄録集 16 2018 3 3 7 2 4 43 TEL 06 6962 7001 594 1101 840 TEL 0725 56 1220 56 16 MHC 2018; 25 (1) 参加費 1 2,000 2 1,000 3 3,000 会議等 1 3 3 13:00 13:10 2 3
More information日本組織適合性学会誌第20巻2号
Major Histocompatibility Complex 2013; 20 (2): 121 129 平成 25 年度認定 HLA 検査技術者講習会テキスト HLA 1) 1) HLA HLA HLA PRA Panel reactive antibody DSA Donor specific alloantibody class subclass non-hla HLA キーワード :Human
More informationMajor Histocompatibility Complex 2018; 25 (2): 抄録集 2 HLA A 3 128
Major Histocompatibility Complex 2018; 25 (: 128 138 抄録集 2018 4 14 A 3 128 MHC 2018; 25 ( HLA 2013 10.5 10 8 12 10 8 2016 CD34 + HLA NC 10 8 CD34 + CD34 + 10 6 NC10.5 2013.Apr 2014.Mar NC11 2014.Apr 2016.Jun
More informationMHC 2013; 20 (1) 11 参加費 1 2, , ,000 会議等 :50 14: :30 13: :00 会場地図 参天製薬株式会社本社案内図 TEL 新大阪駅より
Major Histocompatibility Complex 2013; 20 (1): 63 89 抄録集 11 2013 2 2 3 9 19 TEL: 06 6321 7000 630 0293 1248 1 TEL: 0743 77 0880 E-mail: tubaki@nara.med.kindai.ac.jp 63 MHC 2013; 20 (1) 11 参加費 1 2,000 2
More information特集・総説(44行)/P494~504_総説 佐治(4C)
494 Vol. 45, No. 5 HLA HLA HLA Transplantation and HLA antibody: posttransplantation HLA antibody monitoring and HLA type & screen to overcome technical and logistic limitations Hiroh SAJI HLA Laboratory,
More information-. -. CD Threshold Noise Discrimination CD CDbight+ CDdim CD は
CD34 JCCLS H3-P V1.0 Report of the Hematology Standardization Committee Guidelines for CD34+ Cell Determination by Flow CytometryJCCLS H3-P V1.0 日本臨床検査標準協議会血液検査標準化検討委員会フローサイトメトリーワーキンググループ Japanese Committee
More information<8DD AA97A3834C B BF8A69838A C8EA E786C7378>
ST-01738 ErythroClear Red Blood Cell Depletion Reagent kit 臍帯血 2 ml 用 17,000 13,600 ST-01739 ErythroClear Red Blood Cell Depletion kit 臍帯血 2 ml 用 475,000 380,000 ST-07801 Lymphoprep 250 ml 17,000 13,600
More informationBreakthrough technology that sets the new standard for flow cytometry 2 BD FACSCanto II
BD FACSCanto TM II Innovation with Impact Breakthrough technology that sets the new standard for flow cytometry 2 BD FACSCanto II 1973 BD 30 BD FACS 14,000 BD FACSCanto II BD FACSCanto II 3 BD FACSCanto
More informationサイトメトリー20-2.indd
Nobutaka Kiyokawa M.D., Ph.D. 1, 2), Keiko Onda M.D., Ph.D. 1, 2, 3), Kunihiko Takano C.C. 4), Junichiro Fujimoto M.D., Ph.D. 1, 2), Atsushi Manabe M.D., Ph.D. 2, 5), Katsuyoshi Ko M.D., Ph.D. 2, 6), Akira
More informationCBA Kit Manual Human
BD Pharmingen Cytometric Bead Array (CBA) Kit Manual Human Th1/Th2 Cytokine CBA BD Biosciences Section 1 1 Multiplexing BD Cytometric Bead Array CBA Multiplexing BD CBA CBA ELISA ELISA BD Human Th1/Th2
More informationサイトメトリー20-1.indd
The role of NK cell receptor-expressing cell on anti-leukemia/cancer immunological effect Junji Tanaka, M.D., Ph.D. Hematology and Oncology, Hokkaido University Graduate School of Medicine Abstract NK
More informationUnderstanding Stem Cell Transplant 2007
Understanding Stem Cell Transplant IMF International Myeloma Foundation 12650 Riverside Drive, Suite 206 North Hollywood, CA 91607 USA Telephone: 800-452-CURE (2873) (USA & Canada) 818-487-7455 Fax: 818-487-7454
More informationuntitled
2008/02/05 Isoiso FACSCalbur 488nm FL1 530/30 FITC GFP alexa488 FL2 585/42 PE Cy3 PI FL3 650LP Percp PC5 PI PE-C 7 Red APC Falcon BD Calibrite 3 BD No.340486 DNA QC particles BDNo.349523 Flow-Cheak(10um)
More informationApplication Note 2
A P P L I C A T I O N N O T E 2 CD8 CD4T I M M U N E F U N C T I O N FastImmune Cytokine System T T 3 H- 51 Cr T TMHC- 1, 2 Enzyme-Linked Immunospot ELISPOT 3, 4 5-7 in vitro 3 ELISPOT T 8, 9 T /MHC T
More informationMHC 2013; 20 ( 2 QC QC DNA-QC 3. QCWS 集会参加および参加証明書発行 QCWS QCWS QCWS 解析方法 DNA-QC Luminex SSO SSO SSP SBT QC FlowPRA Lab Screen WAK Flow ICFA 4 HL
Major Histocompatibility Complex 2013; 20 (: 13 16 QCWS # 1. ワークショップの経過 24 1 QCWS HP QCWS 24 2 57 DNA-QC 53 QC 38 1 20 QCWS DNA-QC QC 4 QCWS 4 4 4 16 QCWS 5 21 57 DNA-QC 53 QC 37 5 6 7 HP 8 25 HP 2. QCWS
More information日本消化器外科学会雑誌第29巻第9号
Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe
More informationBD FACSArray BD FACSArray Unlimited Possibilities BD BD FACS BD FACSArray 96 2 BD FACSCalibur 4 Count 0 100 200 300 400 500 600 96 BD Cytometric Bead Array CBA Flex Set ELISA Western Blot Propldi Ce BD
More informationGallios_1312.indd
TM Gallios Gallios 4 Laser System Powerful Versatile Performance Fast Track to Success CE9904 2013.12-2000E Gallios High End Flow Cytometer 1 2 Accuracy 60 50 40 30 20 10 0-10 Log Decade Display Gallios
More informationWelcome to a ore Colorful World BD BD Horizon Brilliant Violet x 1, Lymph x 1, CD3+ CD8 PerCP-Cy5-5-A CD4+ 5 1
Brilliant Violet マルチカラー トレーニング キャンペーン BD Brilliant Violet 2 ( ) 1 ( ) P12 Brilliant Violet Welcome to a ore Colorful World BD BD Horizon Brilliant Violet x 1, 5 1 15 2 25 Lymph x 1, 5 1 15 2 25 CD3+ CD8
More informationKey words: pure red cell anemia, allogeneic bone marrow transplantation.
Complete Recovery of Hemopoiesis Following Bone Marrow Transplantation in a Patient with Unresponsive Congenital Pure Red Cell Anemia Masami SHIMADA, Hideo MUGISHIMA, Mitsuhiko HARA, Masahiro MISAWA, Hideo
More informationALDEFLUOR® 造血幹細胞/造血前駆細胞の新しい同定試薬
ALDEFLUOR Immunophenotyping ALDEFLUOR Primitive Mature or ALDH Aldehyde Dehydrogenase(ALDH) ALDH Stemness ALDH Primitive Mature ALDEFLUOR Intracellular enzymatic assay ALDEFLUOR BAAA ALDH BAA ALDH BAA
More informationuntitled
ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504
More informationCytoFLEX Family Brochure
CytoFLEX Family CytoFLEX CytoFLEX CytoFLEX CytoFLEX CytoFLEX 1 CytoFLEX S 1 CytoFLEX LX 21 2 EVERY ERY Event Matters ters CytoFLEX 1 T T IR CD8 IR CytoFLEX / Karen Hogg, PhD, Bioscience Technology Facility,
More informationThe Molecular Probes Handbook, 11th Edition 3, The Molecular Probes Handbook www. thermofisher.com/handbook Fluorescen
The Molecular Probes Handbook, 11th Edition 3, The Molecular Probes Handbook www. thermofisher.com/handbook www.thermofisher.com/antibodies Fluorescence SpectraViewer 14 www.thermofisher.com/spectraviewer
More informationDynalTransplantDiagnostic.indd
2011 1 SeCore HLA SBT 1 2 AllSet + Gold SSP HLA 7 3 SSP UniTray HLA 11 4 27 5 32 ii 1 SeCore HLA SBT SeCore 2 SeCore HLA SBT SeCore 3 SeCore 4 HLA-I 5 HLA-II 5 utype 5 GSSP 6 1 SeCore HLA SBT Sequencing
More information: / FDA HBsAg HIV 1/2 HCV : QMS : 3.5% IgM () 1.0% H317 - H334 - : : :: : QMS Everolimus : 6.4% (II) H400 - H % SDS QMS EDTA (K 3 ) EDTA (K 2 )
QMS (EVER) 0373852 (QMS) QMS QMS X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
More informationAmnis TM CellStream TM CellStream TM
Amnis TM CellStream TM CellStream TM Amnis TM CellStream TM Amnis TM CCD FITC PE 5 96 7 CFR Part FDA TM CellStream Luminex Time Delay Integration TDI CellStream. 7... CCD CellStream Amnis CCD CellStream
More informationStudies on the Antigens Expressed on Trophoblasts Related to MLR-blocking Antibodies Shigenori GOTO Department of Obstetrics and Gynecology, Niigata University School of Medicine (Director: Prof. Shoshichi
More informationmyeloperoxidase MPO FCM CD.,CD.,CD., CD.,CD., HLA-DR., MPO. CD, CD, CD, CD, CD, CD, CD, CD, CD, CD b, CD, CDa, CD, TdT CD +CD +,XY,addition q/ French-
症例報告 岡智子 1,2), 室井一男 1,2), 森政樹 1,2), 松山智洋 1,2), 藤原慎一郎 1), 翁家国 1), 佐藤一也 1), 上田真寿 1), 鈴木隆浩 1), 尾崎勝俊 1), 永井正 1) 1,2), 小澤敬也 要 約 acute myeloblastic leukemia: AML minimal residual disease MRD AML AML CD +CD +CD
More informationuntitled
Data cleaning Original datan=8479 NCC/ptkgN=7958 NCC10x10E628 8139 NCC/kgPage 1-2) Covariate cleaningcovariate Page Page5-8 Kaplan-Meier method, Log-rank, Cox hazard model Overall survival Cumulative incidence
More information「産業上利用することができる発明」の審査の運用指針(案)
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
More information日本組織適合性学会誌第23巻1号
Major Histocompatibility Complex 2016; 23 (1): 39 44 総 説 1) 1) 1) 1) 2) 2) 2) 2) 2) 2) 1) 2) ABO A/B A/B-IgG A/B-IgG A/B-IgG ABO キーワード : A/B A/B FCM-C1q FCM-IgG はじめに ABO CD20 Rituximab: Genetech, San Francisco,
More informationROWCatPathology_J.book
www.dako.jp IHC Solution Visualization Systems Number of Steps 5 4 3 2 1 LSAB TM 2 EnVision TM G 2 Doublestain EnVision TM DuoFLEX Doublestain LSAB TM + EnVision TM G 2 EnVision TM + EnVision TM FLEX 1
More information1990 preimplantation genetic diagnosis: PGD ( )
Title Author(s) 日本における受精卵診断をめぐる論争 (1990 年代 ) - 争いの経過 - 利光, 恵子 Citation 医療 生命と倫理 社会. 7 P.67-P.85 Issue Date 2008-03-20 Text Version publisher URL https://doi.org/10.18910/12560 DOI 10.18910/12560 rights
More information(Microsoft Word - FACSCanto User Guide\272\353\302\262\252\251.doc)
BD FACSCanto BD FACSCanto 流式細胞儀 488nm 20mw 633nm 17mw 6 2 0.1% 120uL/min 10,000events/sec BD FACSCanto 1 BD FACSCCanto BD FACStation 1.1 FACSCanto BD FACSCanto 2 1.1.1 Fluidics Sample injection tube Aspirator
More information11550_RKL_タグ付抗体カタログp
2 3 4 5 6 8 9 10 10 11 11 12 page2 page3 page4 page5 page6 page7 DyLight 蛍光標識試薬 DyLight Blue 405 (nm) 400/420 スペクトル モル吸光係数 (M 1 cm 2 ) 30K 使用目的 蛍光顕微鏡 フローサイトメトリー ELISA ウエスタンブロット検出 FRET ベースの解析など 類似のスペクトルをもつ色素
More information44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
More informationi ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
More informationThe Molecular Probes Handbook, 11th Edition 3, The Molecular Probes Handbook Flu
Molecular Probes Molecular Probes The Molecular Probes Handbook, 11th Edition 3, The Molecular Probes Handbook www.lifetechnologies.com/handbook www.lifetechnologies.com/antibodies Fluorescence SpectraViewer
More information,,.,.,,.,.,.,.,,.,..,,,, i
22 A person recognition using color information 1110372 2011 2 13 ,,.,.,,.,.,.,.,,.,..,,,, i Abstract A person recognition using color information Tatsumo HOJI Recently, for the purpose of collection of
More informationA13 C A139 A137 A131 A138 V CV FC/SMA 2.51/2.5 MM FF 4 4 5 5 6 A11971 A136 ND A132 1 mm ND1 % 1 %2 6 7 7 A133-9 15 mm 8 A134-9 A135 A135-9 A1127 A1858 A176 A1859 C A11213 C A9865 45V R T 11 15 mm XY XZ
More information20 2008 ( bone collar Hematoxlyin-Eosin staining Alizarin Red S / Alcian Blue staining 1
More informationqxd
BD Pharmingen TM BrdU Flow Kit FITC BrdU Flow Kit 559619 50 557891 4 50 APC BrdU Flow Kit 552598 50 557892 4 50 2005 Becton, Dickinson and Company. All rights reserved. BD Biosciences Becton, Dickinson
More informationuntitled
COLAK Mehmed 11000 305 305 180 10000 9000 8000 160 140 120 7000 100 6000 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 80 GH IGF-1 GH GH 5 4 3 2 1 0 2 3 4 5
More information免疫学研究のための製品群
ver.1.4 The path to new discoveries From basic to clinical research in immunology Good research starts with happy cells. gentlemacs TM Octo Dissociator with Heaters TM Whole Blood MicroBeads 37 RNA Option
More informationXM と併用し高感度な DSA 検出法として FCXM- した cold 生理食塩水でリンパ球を洗浄後 flow IgG を導入した 全米臓器共有ネットワーク United cytometer FACS Calibur Becton, Dickinson and Network for Organ
技術論文 腎臓移植におけるヒトリンパ球を使用した高感度クロ スマッチ検査の検討 小林 悠梨 1) 岩藤 和宏 2) 石塚 敏 1) 中島 一朗 2) 安尾美年子 1) 渕之上昌平 2) 1) 東京女子医科大学中央検査部移植関連検査室 162-8666 2) 東京女子医科大学腎臓外科 要 三浦ひとみ 1) 東京都新宿区河田町 8-1 旨 臓器移植では 液性拒絶反応の免疫学的評価としてドナー特異的抗 HLA
More information1 HLA MHC 2017; 24 (2) HLA HLA 1967 HLA HLA HLA HLA 1980 HLA HLA ABO HLA 2000 HLA DSA 2010 HLA HLA HLA HLA HLA HLA HLA HLA HLA GVHD HLA HLA
Major Histocompatibility Complex 2017; 24 (2): 150 157 抄録集 1 HLA 2017 5 13 150 1 HLA MHC 2017; 24 (2) HLA 1960 1964 HLA 1967 HLA HLA HLA HLA 1980 HLA HLA ABO HLA 2000 HLA DSA 2010 HLA HLA HLA HLA HLA HLA
More information第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
More informationB Violet Laser Tools(JPN) indd
Molecular Probes CD8 Zenon Pacific Orange Qdot 655-CD3 (655/2) : Pacific Blue Pacific Orange Qdot Pacific Blue Pacific Orange Pacific Blue dye 455 nm Pacific Orange dye 551 nm 1 1 Pacific Blue Pacific
More informationMHC23-3
Major Histocompatibility Complex 2016; 23 (3): 168 184 1) 2) 3) 4) 5) 1) 6) 7) 8) 1) 2) 3) 4) HLA 5) 6) 7) 8) HLA 11 25 28 10 22 1 4 61 44 6 1 10 11 5 HLA 60 3 27 3 5 9 5 10 19 5 50 22.4 5.9 8.2% 78.7%
More information蛍光標識抗体の組み合わせによる測定値への影響
3: 51-55, 21 蛍光標識抗体の組み合わせによる測定値への影響 -フローサイトメトリー測定による赤血球 CD59 発現の偽陰性化 - 佐藤晶子 加藤奈津子 福井智津子 櫻井秀子筑波大学医学系技術室 35-8575 茨城県つくば市天王台 1-1-1 概要 細胞表面抗原の分析には フローサイトメトリーによる測定が広く用いられている 今回 赤血球膜蛋白に特有な CD235a と補体制御膜蛋白 CD59
More information骨髄異形成症候群に対する 同種造血幹細胞移植の現状と課題
第 36 回造血幹細胞移植委員会 (H25.2.4) 資料 5 第 36 回厚生科学審議会疾病対策部会造血幹細胞移植委員会 日本造血細胞移植学会 (JSHCT) 移植医療の現場からの提言 日本造血細胞移植学会理事長 岡本真一郎 我が国における非血縁者間造血幹細胞移植数 2000 1800 1600 1400 1200 1000 800 600 400 200 非血縁者間骨髄移植非血縁者間臍帯血移植
More informationA Light source Power supply B Arbitrary unit (au) (Relative intensity) Arbitrary unit (au) (Relative intensity) Wave length : : 550-740 nm nm 160 160 120 120 80 80 40 40 5~20 cm cm Fan Fan3737 o C o C
More information051
Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS 58 4 389( 15 ) 1. MDS collagenase 2. 1 3. 4. / 390( 16 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 4 Aug. 4 4 2004 10 2 1 NTT Aug. THE JAPANESE JOURNAL OF ANTIBIOTICS
More informationサイトメトリー12-1.indd
FCM gating Problems of Flow cytometric gating for hematopoietic cell analysis in clinical test. Kazuto Tsuruda, Tetsuya Usui, Kozue Yoshii, Mihoko Murai, Yusuke Mori, Tomohiro Tsuji, Shinichiro Oguni,
More information免疫Ⅱ
100 100 100 1990 127 DNA DNA DNA DNA hybridization DNA RNA DNA DNA 128 12 µδγαε 129 300 1,200 500 50012 4 24,000 1,20024,000 2.910 7 10 8 rejection major histocompatibility complex MHC MHC MHC 130 MHC
More information研究成果報告書(基金分)
(1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant
More informationFas and Ley antigen expression in polymorphonuclear leukocytes. Satoshi Nishizawa, Yukihiro Numabe and Kyuichi Kamoi Department of Periodontology, School of Dentistry at Tokyo, The Nippon Dental University
More informationVol No Naonori Kumagai Masaei Onuma Masahiro Irie Youhei Watanabe Noriko Sugawara Fumiaki Kamada Tetsuji Morimoto Hidekazu Nishimura Yoshiaki Kondo an
Naonori Kumagai Masaei Onuma Masahiro Irie Youhei Watanabe Noriko Sugawara Fumiaki Kamada Tetsuji Morimoto Hidekazu Nishimura Yoshiaki Kondo and Shigeru Tsuchiya Department of Pediatrics, Tohoku University
More information8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
More informationuntitled
---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14
More informationuntitled
Shinichiro Okamoto MD, PhD Keio University School of Medicine Tokyo Japan vincristine) Berberidaceae etoposide VP-16) MRD 10 12 PCR 10 10 10 8 10 6 10 4 10 2 ( CR) ( CR) AML Study n Ind Consol % 3
More informationBrdU Flow Kit
BrdU FLOW KIT Kit Manual FITC -anti-brdu Antibody (Kit Component. No. 23614L) Cytofix/Cytoperm Buffer (Kit Component. No. 2090KE) Perm/Wash Buffer (10x (Kit Component. No. 2091KE) Cytoperm Plus Buffer
More informationMicrosoft Word - Ⅱ-43.doc
未承認薬 適応外薬の要望 ( 別添様式 1) 1. 要望内容に関連する事項要望者 ( 該当する 学会ものにチェ ( 学会名 ; 日本造血細胞移植学会 ) ックする ) 患者団体 ( 患者団体名 ; ) 個人 ( 氏名 ; ) 優先順位 7 位 ( 全 14 薬剤要望中 ) 要望する医薬品 要望内容 成分名 ( 一般名 ) 販売名 会社名 国内関連学会 未承認薬 適応外薬の分類 ( 該当するものにチェックする
More informationISO
ISO ISO ISO(International Standardization Organization) 135 ISO CD(Committee Draft) DIS(Draft for International Standard) FDIS(Final DIS) ISO ISO23500 2004.01.13 ANSI/AAMI RD52 2004.04.13 6 2004.08.09
More informationMajor Histocompatibility Complex 2017; 24 (3): II MHC MHC Precision Medicine HLA personalized medicine precision medicine
24 3 29 12 20 27 171 30 172 22 HLA-QC 175 30 HLA 182 183 30 HLA 190 30 192 30 HLA 194 29 HLA 196 29 HLA 198 J.J. van Rood 215 16 217 28 219 MHC 28 2 1 220 223 Major Histocompatibility Complex Official
More informationApplication Note 3
A P P L I C A T I O N N O T E 3 R E A G E N T S Dendritic Cell Identification Dendritic Cell: DC T 1 B T 1 2-4 1, 5, 6 negative selection 7-11 lineage marker lin CD83 CMRF-44 12-15 IL-3 α IL-3Rα 16 IL-3Rα
More informationKey words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
More information21 e-learning Development of Real-time Learner Detection System for e-learning
21 e-learning Development of Real-time Learner Detection System for e-learning 1100349 2010 3 1 e-learning WBT (Web Based training) e-learning LMS (Learning Management System) LMS WBT e-learning e-learning
More informationNotePC 8 10cd=m 2 965cd=m 2 1.2 Note-PC Weber L,M,S { i {
12 The eect of a surrounding light to color discrimination 1010425 2001 2 5 NotePC 8 10cd=m 2 965cd=m 2 1.2 Note-PC Weber L,M,S { i { Abstract The eect of a surrounding light to color discrimination Ynka
More information1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 () - 1 - - 2 - - 3 - - 4 - - 5 - 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57
More informationuntitled
2010 58 1 39 59 c 2010 20 2009 11 30 2010 6 24 6 25 1 1953 12 2008 III 1. 5, 1961, 1970, 1975, 1982, 1992 12 2008 2008 226 0015 32 40 58 1 2010 III 2., 2009 3 #3.xx #3.1 #3.2 1 1953 2 1958 12 2008 1 2
More informationi
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
More information細胞増殖測定細胞染色プロトコル
Cell Counting Kit Cell Counting Kit -8 3 Cell Counting Kit -F -Cellstain- -Cellstain- -Cellstain- Calcein-AM solution -Cellstain- CytoRed solution -Cellstain- BCECF-AM special packaging -Cellstain- -Cellstain-
More information20-第14回抄録集.indd
Major Histocompatibility Complex 2016; 23 (1): 45 71 抄録集 14 2016 2 6 7 2 4 43 TEL 06 6962 7001 HLA 600 8813 134 1 2F TEL 075 313 5201 FAX 075 313 5202 E-mail:hla@hla.or.jp 45 MHC 2016; 23 (1) 第 14 回日本組織適合性学会近畿地方会
More information24 Region-Based Image Retrieval using Fuzzy Clustering
24 Region-Based Image Retrieval using Fuzzy Clustering 1130323 2013 3 9 Visual-key Image Retrieval(VKIR) k-means Fuzzy C-means 2 200 2 2 20 VKIR 5 18% 54% 7 30 Fuzzy C-means i Abstract Region-Based Image
More information小児感染免疫第25巻第2号
2013 Vol. 25No. 2175 44 1972 28 1 Kikuchi s diseasekikuchifujmoto diseasehistiocytic necrotizing lymphadenitis Histiocytic necrotizing lymphadenitis, Kikuchi s disease, KikuchiFujimoto disease, subacute
More information第1部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
More information立命館21_松本先生.indd
2143-552010 1 2 () 1 2 3 456 78- Key Words 1 3 12007 2 3 508 19992008 1 23 4 43 2120107 4 2008 1992 2003 2005 1989 2008 4 2 2-1 10 4 4 6 5 4 5 2946 1 155 11 41 44 45 4 2-2 2003 1 21 2 1 3 4 5 6 7 3 2120107
More information立命館20_服部先生.indd
20 93-105 2010 2 () ' - 1 ( ) ( ' 2005) Key Words 2 1967 93 20 2010 1 94 1 ' 2002 2 2 1996 1996 1999 2 2 2 1993 1999 4 1 2 1985 1989 1986 1994 4 1 2 1 1 4 2 4 4 1 4 1966 4 10-1970 20 1993-1972 95 20 2010
More information1996 2000 2004 1984 2005 7150 000 9 500 9 4 13 10 95 11 11 12 20002004 9 70
14 2006 1 Key Words 2002 3 1 2 3 3 1 2 3 1969 1987 69 1996 2000 2004 1984 2005 7150 000 9 500 9 4 13 10 95 11 11 12 20002004 9 70 14 2006 1 15 71 72 1 22 6 32 9 200 6 3 1 2 2000 10 1 2003 10 2005 6 5 4
More information立命館16_坂下.indd
1669-792008 1 - ' 85- -108 ' Key words 1 2 2003 69 1620082 5 3 1990 1997 4 5 2001 1307 6 7 1 1 1 1996 100 2 1997 71 3 1998 71 4 1999 96 5 2000 95 6 2001 145 7 2002 191 8 2003 174 9 2004 120 10 2005 122
More information立命館人間科学研究No.10
1 77 5 Key words 1 23 3 11417 14310045 20022004 2 2003 20022005 20022004 2 10200511 3 2003 1152003 59 1995 3 32003 19932002 20032003 2005 20052005 4 1997 2000521986 2001 42001 3 1981 6 1 7 5 1000248 1632647
More information立命館21_川端先生.indd
21 119-132 2010 ( ) ' Key Words 119 21 2010 7 1962 2001 2001 2007 1982 1988 1997 2007 1997 1998 1863 1880 1 1998 1998 2001 1599 120 121 1599 1695 8 1695 1714 4 1714 1715 5 1715 100 1812 9 1812 1864 2001
More information立命館14_前田.indd
1499-1122007 1 ) ) ) ) ) (1) -- ) ) ) ) ) ) ( ) ) ' ) ) ) ) - 1) 2)' 3) Key words 19811994 1721 99 1420073 100 20012004 2005 2004 2002 33 34 10 1987 45 20002003 2002 1 1 2000 1 1 2001 2 200341 12004 2
More information立命館17_坂下.indd
1793-1052008 1 () -- -- - Key words 1 93 1720088 2 3 2003 15 1996 50 3040 2 3 4050 50 10 1980 1995 1950 1958 1968 1972 94 95 1987 4 4 70 3 3 1 2000 2001 4 1720088 96 2001 2003 2 1978 1990 1997 130 2 3
More information